Size Matters: Why EV Subpopulations Deserve a Closer Look

EV preparations aren’t one uniform population. A growing body of work shows that separating EVs by size reveals subpopulations with different cargo and different biological activity.

Cardiac repair: SEC-separated cardiac progenitor small EVs fell into three subpopulations. The smallest and mid-sized fractions were the most pro-angiogenic and anti-fibrotic, and the largest was inactive in every functional assay. (van de Wakker et al., J Extracell Vesicles, 2024)
MSC-derived EVs: A scalable TFF + SEC workflow produced two umbilical cord MSC subpopulations. One was more immunomodulatory and the other was more pro-angiogenic. The differences carried into disease models and were linked to ESCRT-dependent vs. lipid-raft biogenesis. (Liu et al., J Extracell Vesicles, 2025)
Follicular fluid: Small and large EVs carried different ncRNA profiles and changed granulosa cell gene expression in different ways. (Varik et al., J Extracell Vesicles, 2025)

What this means for EV developers: Size-based fractionation is becoming more than a cleanup step. It can help you find the most active fraction, cut variability between batches and sharpen your mechanism-of-action data. SEC remains one of the most accessible, scalable ways to do it.

Our role: The Column Packing Company packs customer-supplied resins into tested, ready-to-use single-use columns, so your team can focus on the biology instead of packing columns. [Contact us] to discuss your EV workflow.

Sources: